Prestige Consumer Healthcare Inc. PBH
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -20.47%
- 1 year
- -18.60%
- Open
- 50.23
- Prev close
- 48.75
- Mkt cap
- 2.32B
- Vol
- 371.49K
- Avg vol
- 563.58K
- EPS
- 3.57
- P/E
- 13.74
- Div yield
- 0.00%
More statistics
- Low
- 48.78
- High
- 50.15
- Forward P/E
- 9.66
- Beta
- 0.34
- Short ratio
- 6.28
- Inst. own
- 116.91%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 48.56
- 200-d avg
- 54.17
- 1y target
- 67.80
2Y chart
Events in this range
- Aug 7, 2025Earnings: 0.95; estimate 1.01; surprise -5.94%
- Oct 27, 2025Rating: Jefferies · Hold → Hold
- Nov 6, 2025Earnings: 1.07; estimate 0.97; surprise 10.31%
- Nov 7, 2025Rating: Canaccord Genuity · Buy → Buy
- Feb 2, 2026Rating: Jefferies · Hold → Hold
- Feb 5, 2026Earnings: 1.14; estimate 1.16; surprise -1.72%
- May 7, 2026Rating: Oppenheimer · Outperform → Outperform
- May 13, 2026Earnings: 1.23; estimate 1.39; surprise -11.51%
- May 14, 2026Downgrade: Oppenheimer · Outperform → Perform
- May 15, 2026Rating: Canaccord Genuity · Buy → Buy
- Aug 6, 2026Earnings: 0.98; estimate 0.894; surprise 9.62%
Signals (75)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 2026 | 3 days ago |
| MACD: Buy Signal | Oct 29, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 27, 2026 | 5 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| RSI: Oversold | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| RSI: Oversold | May 14, 2026 | 5 months ago |
| RSI: Oversold | May 11, 2026 | 5 months ago |
| MACD: Sell Signal | May 5, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 14, 2026 | 6 months ago |
| RSI: Oversold | Apr 2, 2026 | 7 months ago |
| RSI: Oversold | Mar 13, 2026 | 7 months ago |
| SMA: Bearish | Mar 10, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Mar 3, 2026 | 8 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 25, 2026 | 8 months ago |
| SMA: Bearish | Feb 24, 2026 | 8 months ago |
| SMA: Bullish | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 12, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 27, 2026 | 9 months ago |
| RSI: Overbought | Jan 22, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 2, 2026 | 10 months ago |
| SMA: Bullish | Dec 12, 2025 | 10 months ago |
| SMA: Bearish | Dec 11, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 22, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 7, 2025 | 1 year ago |
| RSI: Oversold | Aug 7, 2025 | 1 year ago |
| RSI: Oversold | Jul 31, 2025 | 1 year ago |
| RSI: Oversold | Jul 29, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| RSI: Oversold | Jul 10, 2025 | 1 year ago |
| RSI: Oversold | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jun 25, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 16, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 8, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | May 2, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 29, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 31, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 11, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 7, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 27, 2025 | 1 year ago |
| SMA: Bullish | Feb 6, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 6, 2025 | 1 year ago |
| RSI: Overbought | Feb 6, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 4, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 16, 2025 | 1 year ago |
| RSI: Oversold | Jan 10, 2025 | 1 year ago |
| RSI: Oversold | Jan 6, 2025 | 1 year ago |
Key statistics
- Market cap
- 2.32B
- Enterprise value
- 4.29B
- Trailing P/E
- 13.75
- Forward P/E
- 9.66
- PEG ratio
- 1.54
- Price / sales
- 2.10
- Price / book
- 1.21
- EPS (TTM)
- 3.57
- Beta
- 0.34
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 15.57%
- Revenue (TTM)
- 1.10B
- Revenue growth
- 6.50%
- Free cash flow
- 147.89M
- Total cash
- 89.13M
- Total debt
- 2.07B
- Return on equity
- 9.12%
- Shares outstanding
- 47.37M
- Short % of float
- 10.09%
- 50-day average
- 48.56
- 200-day average
- 54.17
Analyst view
Consensus: none
- Target (low)
- 55.00
- Target (mean)
- 67.80
- Target (high)
- 75.00
- Strong buy1
- Buy4
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 1.07.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 1.07 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.894 | 0.98 | +0.09 | +9.62% |
| May 13, 2026 | Mar 31, 2026 | 1.39 | 1.23 | -0.16 | -11.51% |
| Feb 5, 2026 | Dec 31, 2025 | 1.16 | 1.14 | -0.02 | -1.72% |
| Nov 6, 2025 | Sep 30, 2025 | 0.97 | 1.07 | +0.10 | +10.31% |
| Aug 7, 2025 | Jun 30, 2025 | 1.01 | 0.95 | -0.06 | -5.94% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 15, 2026 | Canaccord Genuity | main | Buy | Buy |
| May 14, 2026 | Oppenheimer | down | Outperform | Perform |
| May 7, 2026 | Oppenheimer | main | Outperform | Outperform |
| Feb 2, 2026 | Jefferies | main | Hold | Hold |
| Nov 7, 2025 | Canaccord Genuity | main | Buy | Buy |
| Oct 27, 2025 | Jefferies | main | Hold | Hold |
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- prestigebrands.com
News
- Riverwater Small Cap Strategy Q3 2026 Portfolio Update
- Prestige Consumer Healthcare Inc (PBH) Shares Fall 3.4% -- What GF Score of 70 Tells Investors
- Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
- Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
- Transcript: Prestige Consumer Q1 2027 Earnings Conference Call
- Amylyx's Avexitide Phase III Win Sets Up FDA Filing for PBH Treatment
- Best Value Stocks to Buy for October 1st
- PBH vs. NEOG: Which Stock Is the Better Value Option?
- More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds
- Premium Brands (TSE:PBH) Reaches New 52-Week Low – Here’s What Happened
Your note
Sign in to keep a note on PBH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BYOM JOHN E | Director | Stock Award(Grant) | Aug 3, 2026 | 54,575 |
| CLARK CLESTEEN A | Director | Stock Award(Grant) | Aug 3, 2026 | 16,511 |
| FRITZ MARY BETH | Officer | Stock Award(Grant) | May 4, 2025 | 17,366 |
| HOPKINS SHEILA A | Director | Stock Award(Grant) | Aug 4, 2025 | 30,123 |
| LOMBARDI RONALD M | Chief Executive Officer | Stock Award(Grant) | May 3, 2026 | 378,205 |
| MEKHAIL ADEL | Officer | Stock Award(Grant) | May 3, 2026 | 26,190 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.53% | 7,831,333 | 384.28M | Jun 29, 2026 |
| Ariel Investments, LLC | 10.28% | 4,868,711 | 238.91M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.96% | 2,825,340 | 138.64M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 5.62% | 2,661,291 | 130.59M | Jun 29, 2026 |
| Fuller & Thaler Asset Management Inc. | 4.92% | 2,331,821 | 114.42M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.51% | 2,136,944 | 104.86M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 2,820,031 | 138.38M | Sep 29, 2026 |
| UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd. | 3.93% | 1,862,014 | 91.37M | Jun 29, 2026 |
| Ariel Investment Trust-Ariel Fund | 3.60% | 1,703,532 | 83.59M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.19% | 1,509,368 | 74.06M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.61% | 1,236,628 | 60.68M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 1,085,728 | 53.28M | Jun 29, 2026 |